dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Casado, Jose A |
dc.contributor.author | Valeri, Antonio |
dc.contributor.author | Sánchez-Domínguez, Rebeca |
dc.contributor.author | Vela Cristobal, Paula |
dc.contributor.author | López, Andrea |
dc.contributor.author | Navarro, Susana |
dc.contributor.author | Díaz de Heredia Rubio, Maria Cristina |
dc.date.accessioned | 2022-09-09T12:50:57Z |
dc.date.available | 2022-09-09T12:50:57Z |
dc.date.issued | 2022-08-01 |
dc.identifier.citation | Casado JA, Valeri A, Sanchez-Domínguez R, Vela P, López A, Navarro S, et al. Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia. J Clin Invest. 2022 Aug 1;132(15):e142842. |
dc.identifier.issn | 1558-8238 |
dc.identifier.uri | https://hdl.handle.net/11351/8119 |
dc.description | Resposta immune cel·lular; Immunologia; Cèl·lules mare |
dc.description.sponsorship | This work was supported by the “Ministerio de Ciencia e Innovación y Competitividad y Fondo Europeo de Desarrollo Regional (FEDER)” (SAF2015-68073-R, SAF2015-64152-R, and RTI2018-097125-B-I00); Next Generation EU; Plan de Recuperación Transformación y Resilencia (Instituto de Salud Carlos III; TERAV) (RD12/0019/0023); Programs of the European Commission (HEALTHF5-2012-305421 and EUROFANCOLEN); the “Ministerio de Sanidad, Servicios Sociales e Igualdad” (EC11/060 and EC11/550 “Comunidad de Madrid” (AvanCell, B2017/BMD-3692); and the ICREA-Academia program. |
dc.language.iso | eng |
dc.publisher | American Society for Clinical Investigation |
dc.relation.ispartofseries | The Journal of Clinical Investigation;132(15) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Anèmia de Fanconi |
dc.subject | Cèl·lules mare hematopoètiques |
dc.subject | Regulació genètica |
dc.subject.mesh | Fanconi Anemia |
dc.subject.mesh | Hematopoietic Stem Cells |
dc.subject.mesh | Up-Regulation |
dc.title | Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1172/JCI142842 |
dc.subject.decs | anemia de Fanconi |
dc.subject.decs | células madre hematopoyéticas |
dc.subject.decs | regulación positiva |
dc.relation.publishversion | http://dx.doi.org/10.1172/JCI142842 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Casado JA, Valeri A, Sanchez-Domínguez R, Vela P, López A, Navarro S] Division of Innovative Therapies, CIEMAT and Advanced Therapies Unit, IIS-Fundación Jimenez Diaz and Autónoma University, Madrid, Spain. Biomedical Center for Research on Rare Diseases (CIBERER), Madrid, Spain. [Díaz de Heredia C] Servei d’Oncologia i Hematologia Pediàtriques, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 35671096 |
dc.identifier.wos | 000842455700003 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |